RhumbLine Advisers’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-100,518
Closed -$3.6M 3047
2014
Q4
$3.6M Sell
100,518
-1,614
-2% -$48.2K 0.01% 980
2014
Q3
$2.65M Sell
102,132
-5,690
-5% -$163K 0.01% 1137
2014
Q2
$3.56M Sell
107,822
-14,531
-12% -$420K 0.01% 986
2014
Q1
$3.66M Sell
122,353
-2,510
-2% -$86.5K 0.01% 979
2013
Q4
$3.79M Buy
124,863
+2,590
+2% +$71.3K 0.01% 970
2013
Q3
$3.89M Buy
122,273
+439
+0.4% +$10.1K 0.01% 937
2013
Q2
$1.84M Buy
+121,834
New +$1.69M 0.01% 1360

Other funds holding NPSP

RhumbLine Advisers's NPSP Position: Q1 2015 in Review

RhumbLine Advisers sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 100,518 shares — an estimated $3.6M sold.

RhumbLine Advisers first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $3.89M in Q3 2013. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • RhumbLine Advisers reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • RhumbLine Advisers sold 100,518 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $3.6M.
  • RhumbLine Advisers first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • RhumbLine Advisers's NPS PHARMACEUTICALS INC position peaked at $3.89M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.